Distinguished in Atherosclerosis

Nobuyoshi Azuma

Asahikawa, JP 
Distinguished in Atherosclerosis
Asahikawa, JP 
OverviewLocationsClinical Research

Overview

Nobuyoshi Azuma practices in Asahikawa, Japan. Mr. Azuma is rated as a Distinguished expert by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Gangrene, Atherosclerosis, Pancreaticoduodenectomy, and Angioplasty.

His clinical research consists of co-authoring 120 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 40 articles and participated in 1 clinical trial in the study of Atherosclerosis.

Gender
Male

Locations

Asahikawa, 0788510, Japan
Other Locations
Nishinomiya-hama, Japan
Midorigaoka, Japan
Amagasaki, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
A Randomized Trial Comparing the Drug-Eluting Stent (DES) Below-the-Knee (BTK) Vascular Stent System (DES BTK Vascular Stent System) vs Percutaneous Transluminal Angioplasty (PTA) Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: July 01, 2024
Intervention Type: Combination product, Device
Study Phase: Phase 3

120 Total Publications

Myeloperoxidase-anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis.
Myeloperoxidase-anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis.
Journal: Scandinavian journal of rheumatology
Published: November 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Azuma's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile